|
| | 
|
 | |
        
|  |
 
|
| PS: The quotes after 2017-05-03 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Teva Pharmaceutic Static Chart |
 Teva Pharmaceutic - [Ticker: TEVA] |     | | Last Trade | 14.01 | Last Trade Time | 2017-11-01 - 19:35:00 | | Variation | +0.21 (+1.52%) | Open | 13.55 | | High | 14.08 | Low | 13.38 | | Volume | 21,287,058 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | 14.01 x 8,100 - 14.02 x 6,000 | | Former Close | 13.80 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
|
News about Teva Pharmaceutic [TEVA]: (ordered by relevance)
| | Fitch Revises Teva's Outlook to Stable; Affirms Ratings at 'BB-' Fitch Ratings
Teva loses bid to cancel Corcept drug patent at Federal Circuit Reuters
Teva Leapfrogs Taro With Authorized Generic Epiduo Forte Launch Generics Bulletin
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement Business Wire
Greenberg Traurig Adds Teva Counsel to Pharma, Health Care Team Bloomberg Law
By selling bonds tied to drug access and climate goals, Teva takes pharma in a new direction - STAT STAT
Pretax profit increases 13% to $364m at Irish arm of Teva The Irish Times
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working? FiercePharma
Teva launches generic of Epiduo Forte Gel in U.S. Seeking Alpha
Teva Pharmaceutical Industries (NYSE:TEVA) shareholders have endured a 76% loss from investing in the stock five years ago Simply Wall St
Smartworks leases 300 seats to Teva Pharma in suburban Mumbai Livemint
Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd. GlobeNewswire
Teva Pharma Highlights Launch Of Authorized Generic Epiduo Forte Gel In US Benzinga
Gan Teva Wraps Up its First ?Semester? Prince William Living
ED Treatment Market Outlook Growth Survey During Pandemic by 2021-2026 | Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, SK Chemicals, Teva Pharma ? UK Parents Lounge UK Parents Lounge
2 Popular Healthcare Stocks I'd Avoid at All Costs The Motley Fool
3 Top Stocks That'll Make You Richer in December (and Beyond) Motley Fool
From Cuyana to Teva Fast Company
Mon: ICL, Perrigo lead strong TASE gains Globes
Investors question green tint of Teva's $5bn sustainability bond Financial Times
5 Warren Buffett Stocks Are Screaming Buys in December Motley Fool
Teva halts output at U.S. drug plant after FDA flags concerns Reuters
Glaxo's Win in Case Against Teva Lifts Other Drugmakers Bloomberg
New branded drugs helping Teva Pharm move closer to growth Reuters
Teva Pharmaceuticals' Motion to Dismiss Denied Policy & Medicine
Why Teva Pharmaceutical Industries Shot Higher Today The Motley Fool
J&J, Teva Beat $50 Billion Opioid Case in First Industry Win Bloomberg
Teva must face government's kickback claims over Copaxone - judge Reuters
Brussels' Teva probe reveals dark side of patent protections Financial Times
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug FiercePharma
Teva and Bioeq Announce Commercial Partnership for Biosimilar Business Wire
Antitrust: Commission opens formal investigation: Teva EU News
Two pharma giants claim Irish-based Teva breached its patents The Irish Times
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats FiercePharma
Teva taps new North American commercial chief as key meds Ajovy, Austedo lag their rivals FiercePharma
Fitch Affirms Teva at 'BB-'; Outlook Remains Negative Fitch Ratings
Why Teva Pharmaceuticals Has Two A-Products In The Bag Seeking Alpha
EXCLUSIVE Teva Pharm unlikely to reach deals to co-produce vaccines -CEO Reuters
Teva reaches $925,000 settlement to resolve drug price-fixing claims PMLiVE
Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October 27, 2021 Business Wire
AstraZeneca, Merck KGaA, Pfizer, and Teva Team up with Tech and Investment Leaders to Launch New Biotech Innovation Lab Pharmaceutical Technology Magazine
EPR Podcast Episode 1 - Richard Daniell, Teva Pharmaceuticals European Pharmaceutical Review
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report Business Wire
Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products, EL (21)A/14 GOV.UK
After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly $16M FiercePharma
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals Business Wire
Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021 Business Wire
Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021 Yahoo Finance
Serial Problem Solver Pharmaceutical Executive
Former Moderna CMO Zaks goes back to his Israeli roots, reemerging as Teva board director FiercePharma
Is Teva Pharmaceutical a Safe Stock to Buy Now? Motley Fool
What To Do After Teva Stock Falls Below $10 Again Seeking Alpha
Teva, Glenmark accuse U.S. government of improperly expanding price-fixing case FiercePharma
Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States Business Wire
Teva and MODAG Tie Up on Potential Parkinson's, MSA Treatment BioSpace
Antitrust: Commission fines Teva and Cephalon ?60.5 million EU News
Teva's Risperidone Injectable Wards Off Schizophrenia Relapse in Phase III BioSpace
Israel-based Teva to invest $42 mln in new drug plant in Bulgaria SeeNews
Is Teva Pharmaceutical Industries (NYSE:TEVA) Using Too Much Debt? Nasdaq
No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds FiercePharma
Teva to close Sudocrem plant in Dublin, 110 jobs to go RTE.ie
Teva Pharm sees growth in two main branded drugs in otherwise flat 2021 Reuters
Generic-Drug Labeling Strategy Likely to Survive Teva Rehearing Bloomberg
Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) Tablets in Adult Patients with Tardive Dyskinesia Business Wire
Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter FDA.gov
Teva Partners With Cotopaxi | Shop-Eat-Surf Shop-Eat-Surf.com
Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United States Business Wire
Johnson & Johnson, AbbVie, Teva and Endo face $50B opioid trial, pharma's first since 2019 FiercePharma
Generic Makers to Challenge Ruling Upholding Teva Cancer Drug Bloomberg Law
Deferasirox-Teva Drug / Medicine Information News-Medical.net
Teva Is in Discussions to Help Make Covid Vaccines, CEO Says Bloomberg
Teva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressure inside the eye, in the United States Business Wire
Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Treatment of Migraine in Adults Business Wire
English High Court finds Bayer patent obvious in win for Teva Life Sciences Intellectual Property Review
Teva: Biosimilars In The US Will Become Like Complex Generics Generics Bulletin
Teva to Host Conference Call to Discuss First Quarter 2021 Financial Results at 8 a.m. ET on April 28, 2021 Business Wire
Teva Enlists Sarah Michelle Gellar to Launch "Inhaler Tales" Campaign to Raise Awareness About Inhaler Use in Asthma and COPD Yahoo Finance
Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors May Contribute to the Significant Under-Diagnosis of Migraine Yahoo Finance
Teva appeals to court to keep 'incredibly damaging' Hollywood parody videos under wraps in New York opioid case Endpoints News
Teva sells its only manufacturing plant in Russia The Pharma Letter
Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate) Business Wire
Teva Sets Ambitious Long-Term Environmental Goals As Part of CSRwire.com
Teva Pharmaceutical's Ice-Cube Business Model Seeking Alpha
Teva Announces the U.S. Launch of its Generic Version of SOOLANTRA® (ivermectin) Cream, 1% for Once Daily Treatment of Rosacea Business Wire
IN BRIEF: Teva to pay $1.1 mln in Intuniv antitrust settlement Reuters
Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021 Business Wire
AbbVie vs.Teva: Which Drug Manufacturing Stock is a Better Choice? Yahoo Finance
Are the Teva ReEmber Shoes So Ugly, They're Good? InStyle
Biogen sues Teva over MS generic Life Sciences Intellectual Property Review
TEVA Pharmaceuticals sells Forest facility to private investor WSET
Teva Canada Provides New Patient Resource to Empower Those Living with Chronic Conditions Business Wire
LoA Update: Teva's extended-release risperidone for schizophrenia sees 5-point boost in regulatory potential following positive Phase III study Clinical Trials Arena
N.Y. jury urged to hold drugmakers liable for U.S. opioid crisis Reuters
GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. | Robins Kaplan LLP - JDSupra JD Supra
Teva Launches TevaForever Recycling Program with TerraCycle | Shop-Eat-Surf Shop-Eat-Surf.com
Teva joins pharma's help-the-helpers trend with campaign for Canada's COVID caregivers FiercePharma
Teva Wins New Hearing in Glaxo 'Skinny Label' Drug Patent Case Bloomberg Law
Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia Business Wire
Teva UK Enters Erectile Dysfunction Category With First Ever Rx-To-OTC Switch HBW Insight
Pinsent Masons advises Teva Pharmaceuticals on ?84m sale of its consumer healthcare brand portfolio to Karo Pharma AB. Out-Law.com
| For more news about Teva Pharmaceutic click here:
Teva Pharmaceutic News |
|
Website Width:
Background image: |
|  | |
|
|
